Thanks to an amazing effort by a fantastic international team, version 2 of the #Cochrane tool for assessing risk of bias in #randomized#trials (#ROB2) has just been published in @bmj_latest. Download from https://t.co/R974IXqm9p @_MiguelHernan
🚨 Funded PhD opportunity 🚨 Work with large-scale electronic health record data from #OpenSAFELY to optimise vaccine effectiveness estimation for respiratory viruses.
Apply here 👉https://t.co/HGNwCHmKkG
We're off and away with Summer School 2025!
Jonathan Sterne is leading our Advanced causal inference course, ably assisted by tutors Ghazaleh Dashti, Marnie Downes, Daisy Shepherd and Jiaxin Zhang from CEBU.
PS. Follow us over on @vicbiostat.bsky.social..
1/
That "immortal time" is so frequent in survival analyses for #causalinference is fascinating.
Because "immortal time" doesn't exist in the data, *we* create it when misanalyzing data.
Our paper https://t.co/2TYg6hHCZj summarizes why immortal time arises & how to prevent it.
New Year training goals? Explore our online intensive short courses for researchers and healthcare researchers - search Bristol Medical School short courses for more info.
📢New paper in @JAMAPsych
Incidence of mental illnesses in unvaccinated people increased for up to one year after severe COVID-19. Findings suggest vaccination may mitigate effects of the disease on #MentalHealth
News https://t.co/SuUqlxdVAy
Paper https://t.co/ilvIcsI0nR
Our latest research:Cohort study of cardiovascular safety of different COVID-19 vaccination doses among 46 million adults in England. Led by Samantha Ip @venexia@jonathanasterne &Angela Wood. Supporting wide uptake of future COVID-19 vaccination programs. https://t.co/b0dCLRDbw2
Our Director's Fund is supporting 3 new projects looking at predicting postoperative complications, empowering young people in their #Digital lives + improving pleural #Mesothelioma prediction.
Congratulations @drrichstrong, @LucyABiddle + Geri Lynch!
News https://t.co/cmcvNdvbl4
The @TARGETGuideline team needs your help.
If you work on #causalinference from observational data, please get involved in piloting the reporting guidelines for #TargetTrial emulation.
Diverse viewpoints will make the guidelines more useful for everyone in #RWE.
More info👇
📢New collaborative project on our site!
'Handling missing data in large electronic healthcare record datasets'
Led by Prof Angela Wood from @Cambridge_Uni, @jonathanasterne + Prof Kate Tilling
Partnering with @BHFDataScience + @HDR_UK
Project page https://t.co/KQF69kGBkQ
New @NatureMedicine
The longest randomized trial assessment—4 years— of semaglutide (Wegovy) in participants without diabetes
https://t.co/P7SBN9cwke
Sustained weight loss, no new side effects noted
The 17th Kolokotrones Symposium, "UK Secure Data Environments: A New Approach to Population-Scale Real World Evidence,” was a success!
Thanks to our speakers for providing valuable insight into the British data model.
Presentations now live on YouTube:
https://t.co/68ixgBgIMH
📢Paper alert!
Read about ROBINS-E, a new tool for assessing risk of bias in observational studies of exposures. Paper by Prof Julian PT Higgins, @jonathanasterne + rest of international team published in @env_int_journal
News https://t.co/D3epJH3WaH
Paper https://t.co/ENvxZgdbad
@_MiguelHernan & @jonathanasterne kick off the 17th Kolokotrones Symposium - UK Secure Data Environments: A New Approach to Population-Scale Real World Evidence.
Check out today's agenda and follow along as we live tweet the event!
https://t.co/kX5lQ4o7At
Excited to be part of the Bristol-Bordeaux Public Health Meeting 2024! Looking forward to the diverse set of talks over the next two days to facilitate research and training collaboration. #UB2PH2024
Compared with no invitation for routine PSA testing, a single invitation for a PSA screening test reduced prostate cancer mortality at a median follow-up of 15 years, but the absolute mortality benefit was small.
https://t.co/tXiy0u50gg
#EAU24